CymaBay Therapeutics Inc. (CBAY) PT Set at $15.00 by Oppenheimer Holdings, Inc.

... biopharmaceutical company's stock valued at $115,000 after buying an additional 10,000 shares in the last quarter. Ardsley Advisory Partners lifted its stake in CymaBay Therapeutics by 66.2% in the 2nd quarter. Ardsley Advisory Partners now owns ...
http://ift.tt/2iMMKC5